Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines.
Saved in:
| Title: | Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines. |
|---|---|
| Authors: | Soleiman M; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Fathi-Roudsari M; Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Khajeh K; Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran., Maghsoudi A; Atra Zist Aray, Tehran, Iran. |
| Source: | Cancer investigation [Cancer Invest] 2024 Apr; Vol. 42 (4), pp. 319-332. Date of Electronic Publication: 2024 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
